Advertisement
Screener

CHAMPIONS ONCOLOGY, INC. (CSBR) Selling and Marketing Expense

2.8 / 5 stars · 68/120 Roast Me

CHAMPIONS ONCOLOGY, INC. Selling and Marketing Expense

CHAMPIONS ONCOLOGY, INC. (CSBR) reported Selling and Marketing Expense of $3.09 million for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-11.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:SellingAndMarketingExpense · last filed 2026-09-11

  • CHAMPIONS ONCOLOGY, INC. selling and marketing expense for the quarter ending 2026-07-31 was $3.09M, a 66.58% increase year-over-year.
  • CHAMPIONS ONCOLOGY, INC. selling and marketing expense for the quarter ending 2026-04-30 was $2.80M, a 21.18% increase year-over-year.
  • CHAMPIONS ONCOLOGY, INC. selling and marketing expense for the quarter ending 2026-01-31 was $2.67M, a 47.62% increase year-over-year.
  • CHAMPIONS ONCOLOGY, INC. selling and marketing expense for the quarter ending 2025-10-31 was $2.00M, a 14.11% increase year-over-year.
  • CHAMPIONS ONCOLOGY, INC. selling and marketing expense for fiscal 2026 was $9.32M, a 23.50% increase from fiscal 2025.
  • CHAMPIONS ONCOLOGY, INC. selling and marketing expense for fiscal 2025 was $7.54M, a 6.81% increase from fiscal 2024.
  • CHAMPIONS ONCOLOGY, INC. selling and marketing expense for fiscal 2024 was $7.06M, a 0.89% increase from fiscal 2023.
  • CHAMPIONS ONCOLOGY, INC. selling and marketing expense for fiscal 2023 was $7.00M, a 9.77% increase from fiscal 2022.
Period endSelling and Marketing Expense 3 monthSelling and Marketing Expense 6 monthSelling and Marketing Expense 9 monthSelling and Marketing Expense 12 month
2026-07-31$3.09M
10-Q · filed 2026-09-11
$5.89M
derived: sum of 2 quarters · filed 2026-09-11
$8.55M
derived: sum of 3 quarters · filed 2026-09-11
$10.55M
derived: sum of 4 quarters · filed 2026-09-11
2026-04-30$2.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-27
$5.46M
derived: sum of 2 quarters · filed 2026-07-27
$7.46M
derived: sum of 3 quarters · filed 2026-07-27
$9.32M
10-K · filed 2026-07-27
2026-01-31$2.67M
10-Q · filed 2026-03-12
$4.66M
derived: sum of 2 quarters · filed 2026-03-12
$6.52M
10-Q · filed 2026-03-12
$8.83M
derived: sum of 4 quarters · filed 2026-09-11
2025-10-31$2.00M
10-Q · filed 2025-12-15
$3.85M
10-Q · filed 2025-12-15
$6.16M
derived: sum of 3 quarters · filed 2026-09-11
$7.97M
derived: sum of 4 quarters · filed 2026-09-11
2025-07-31$1.85M
10-Q · filed 2026-09-11
$4.16M
derived: sum of 2 quarters · filed 2026-09-11
$5.97M
derived: sum of 3 quarters · filed 2026-09-11
$7.72M
derived: sum of 4 quarters · filed 2026-09-11
2025-04-30$2.31M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-27
$4.12M
derived: sum of 2 quarters · filed 2026-07-27
$5.87M
derived: sum of 3 quarters · filed 2026-07-27
$7.54M
10-K · filed 2026-07-27
2025-01-31$1.81M
10-Q · filed 2026-03-12
$3.56M
derived: sum of 2 quarters · filed 2026-03-12
$5.24M
10-Q · filed 2026-03-12
$7.01M
derived: sum of 4 quarters · filed 2026-03-12
2024-10-31$1.75M
10-Q · filed 2025-12-15
$3.43M
10-Q · filed 2025-12-15
$5.21M
derived: sum of 3 quarters · filed 2025-12-15
$7.00M
derived: sum of 4 quarters · filed 2025-12-15
2024-07-31$1.68M
10-Q · filed 2025-09-15
$3.46M
derived: sum of 2 quarters · filed 2025-09-15
$5.25M
derived: sum of 3 quarters · filed 2025-09-15
$7.05M
derived: sum of 4 quarters · filed 2025-09-15
2024-04-30$1.78M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-23
$3.57M
derived: sum of 2 quarters · filed 2025-07-23
$5.37M
derived: sum of 3 quarters · filed 2025-07-23
$7.06M
10-K · filed 2025-07-23
2024-01-31$1.80M
10-Q · filed 2025-03-17
$3.59M
derived: sum of 2 quarters · filed 2025-03-17
$5.29M
10-Q · filed 2025-03-17
$7.14M
derived: sum of 4 quarters · filed 2025-03-17
2023-10-31$1.79M
10-Q · filed 2024-12-16
$3.49M
10-Q · filed 2024-12-16
$5.34M
derived: sum of 3 quarters · filed 2024-12-16
$7.10M
derived: sum of 4 quarters · filed 2024-12-16
2023-07-31$1.70M
10-Q · filed 2024-09-13
$3.54M
derived: sum of 2 quarters · filed 2024-09-13
$5.31M
derived: sum of 3 quarters · filed 2024-09-13
$7.01M
derived: sum of 4 quarters · filed 2024-09-13
2023-04-30$1.85M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-19
$3.61M
derived: sum of 2 quarters · filed 2024-07-19
$5.31M
derived: sum of 3 quarters · filed 2024-07-19
$7.00M
10-K · filed 2024-07-19
2023-01-31$1.76M
10-Q · filed 2024-03-15
$3.46M
derived: sum of 2 quarters · filed 2024-03-15
$5.15M
10-Q · filed 2024-03-15
$6.77M
derived: sum of 4 quarters · filed 2024-03-15
2022-10-31$1.70M
10-Q · filed 2023-12-13
$3.39M
10-Q · filed 2023-12-13
$5.01M
derived: sum of 3 quarters · filed 2023-12-13
$6.56M
derived: sum of 4 quarters · filed 2023-12-13
2022-07-31$1.69M
10-Q · filed 2023-09-13
$3.31M
derived: sum of 2 quarters · filed 2023-09-13
$4.86M
derived: sum of 3 quarters · filed 2023-09-13
$6.50M
derived: sum of 4 quarters · filed 2023-09-13
2022-04-30$1.61M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-24
$3.16M
derived: sum of 2 quarters · filed 2023-07-24
$4.80M
derived: sum of 3 quarters · filed 2023-07-24
$6.38M
10-K · filed 2023-07-24
2022-01-31$1.55M
10-Q · filed 2023-03-16
$3.19M
derived: sum of 2 quarters · filed 2023-03-16
$4.76M
10-Q · filed 2023-03-16
$6.24M
derived: sum of 4 quarters · filed 2023-03-16
2021-10-31$1.64M
10-Q · filed 2022-12-13
$3.21M
10-Q · filed 2022-12-13
$4.69M
derived: sum of 3 quarters · filed 2022-12-13
$6.18M
derived: sum of 4 quarters · filed 2022-12-13
2021-07-31$1.57M
10-Q · filed 2022-09-12
$3.05M
derived: sum of 2 quarters · filed 2022-09-12
$4.54M
derived: sum of 3 quarters · filed 2022-09-12
$5.89M
derived: sum of 4 quarters · filed 2022-09-12
2021-04-30$1.47M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-07-22
$2.96M
derived: sum of 2 quarters · filed 2022-07-22
$4.31M
derived: sum of 3 quarters · filed 2022-07-22
$5.52M
10-K · filed 2022-07-22
2021-01-31$1.49M
10-Q · filed 2022-03-15
$2.84M
derived: sum of 2 quarters · filed 2022-03-15
$4.05M
10-Q · filed 2022-03-15
$5.13M
derived: sum of 4 quarters · filed 2022-03-15
2020-10-31$1.35M
10-Q · filed 2021-12-13
$2.56M
10-Q · filed 2021-12-13
$3.64M
derived: sum of 3 quarters · filed 2021-12-13
$4.95M
derived: sum of 4 quarters · filed 2021-12-13
2020-07-31$1.21M
10-Q · filed 2021-09-13
$2.29M
derived: sum of 2 quarters · filed 2021-09-13
$3.60M
derived: sum of 3 quarters · filed 2021-09-13
$4.58M
derived: sum of 4 quarters · filed 2021-09-13
2020-04-30$1.09M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-26
$2.39M
derived: sum of 2 quarters · filed 2021-07-26
$3.37M
derived: sum of 3 quarters · filed 2021-07-26
$4.24M
10-K · filed 2021-07-26
2020-01-31$1.31M
10-Q · filed 2021-03-15
$2.28M
derived: sum of 2 quarters · filed 2021-03-15
$3.15M
10-Q · filed 2021-03-15
$4.07M
derived: sum of 4 quarters · filed 2021-03-15
2019-10-31$977.00K
10-Q · filed 2020-12-14
$1.85M
10-Q · filed 2020-12-14
$2.77M
derived: sum of 3 quarters · filed 2020-12-14
$3.64M
derived: sum of 4 quarters · filed 2020-12-14
2019-07-31$870.00K
10-Q · filed 2020-09-14
$1.79M
derived: sum of 2 quarters · filed 2020-09-14
$2.67M
derived: sum of 3 quarters · filed 2020-09-14
$3.41M
derived: sum of 4 quarters · filed 2020-09-14
2019-04-30$918.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-07-28
$1.80M
derived: sum of 2 quarters · filed 2020-07-28
$2.54M
derived: sum of 3 quarters · filed 2020-07-28
$3.06M
10-K · filed 2020-07-28
2019-01-31$879.00K
10-Q · filed 2020-03-16
$1.62M
derived: sum of 2 quarters · filed 2020-03-16
$2.14M
10-Q · filed 2020-03-16
$2.85M
derived: sum of 4 quarters · filed 2020-03-16
2018-10-31$740.00K
10-Q · filed 2019-12-16
$1.26M
10-Q · filed 2019-12-16
$1.97M
derived: sum of 3 quarters · filed 2019-12-16
$2.59M
derived: sum of 4 quarters · filed 2019-12-16
2018-07-31$518.00K
10-Q · filed 2019-09-16
$1.23M
derived: sum of 2 quarters · filed 2019-09-16
$1.85M
derived: sum of 3 quarters · filed 2019-09-16
$2.40M
derived: sum of 4 quarters · filed 2019-09-16
2018-04-30$708.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-07-29
$1.33M
derived: sum of 2 quarters · filed 2019-07-29
$1.89M
derived: sum of 3 quarters · filed 2019-07-29
$2.57M
10-K · filed 2019-07-29
2018-01-31$627.00K
10-Q · filed 2019-03-18
$1.18M
derived: sum of 2 quarters · filed 2019-03-18
$1.86M
10-Q · filed 2019-03-18
$2.75M
derived: sum of 4 quarters · filed 2019-03-18
2017-10-31$551.00K
10-Q · filed 2018-12-17
$1.24M
10-Q · filed 2018-12-17
$2.13M
derived: sum of 3 quarters · filed 2018-12-17
$2.85M
derived: sum of 4 quarters · filed 2018-12-17
2017-07-31$683.00K
10-Q · filed 2018-09-14
$1.57M
derived: sum of 2 quarters · filed 2018-09-14
$2.30M
derived: sum of 3 quarters · filed 2018-09-14
$3.02M
derived: sum of 4 quarters · filed 2018-09-14
2017-04-30$892.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-07-30
$1.62M
derived: sum of 2 quarters · filed 2018-07-30
$2.33M
derived: sum of 3 quarters · filed 2018-07-30
$3.26M
10-K · filed 2018-07-30
2017-01-31$726.00K
10-Q · filed 2018-03-19
$1.44M
derived: sum of 2 quarters · filed 2018-03-19
$2.37M
10-Q · filed 2018-03-19
$3.13M
derived: sum of 4 quarters · filed 2018-03-19
2016-10-31$717.00K
10-Q · filed 2017-12-15
$1.64M
10-Q · filed 2017-12-15
$2.40M
derived: sum of 3 quarters · filed 2017-12-15
$3.18M
derived: sum of 4 quarters · filed 2017-12-15
2016-07-31$925.00K
10-Q · filed 2017-09-14
$1.68M
derived: sum of 2 quarters · filed 2017-09-14
$2.46M
derived: sum of 3 quarters · filed 2017-09-14
$3.29M
derived: sum of 4 quarters · filed 2017-09-14
2016-04-30$757.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-07-28
$1.54M
derived: sum of 2 quarters · filed 2017-07-28
$2.37M
derived: sum of 3 quarters · filed 2017-07-28
$3.44M
10-K · filed 2017-07-28
2016-01-31$779.00K
10-Q · filed 2017-03-17
$1.61M
derived: sum of 2 quarters · filed 2017-03-17
$2.69M
10-Q · filed 2017-03-17
$3.58M
derived: sum of 4 quarters · filed 2017-03-17
2015-10-31$834.00K
10-Q · filed 2016-12-14
$1.86M
10-Q · filed 2016-12-14
$2.81M
derived: sum of 3 quarters · filed 2016-12-14
$3.90M
derived: sum of 4 quarters · filed 2016-12-14
2015-07-31$1.03M
10-Q · filed 2016-09-14
$1.97M
derived: sum of 2 quarters · filed 2016-09-14
$3.07M
derived: sum of 3 quarters · filed 2016-09-14
$4.27M
derived: sum of 4 quarters · filed 2016-09-14
2015-04-30$943.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-07-29
$2.04M
derived: sum of 2 quarters · filed 2016-07-29
$3.24M
derived: sum of 3 quarters · filed 2016-07-29
$4.28M
10-K · filed 2016-07-29
2015-01-31$1.09M
10-Q · filed 2016-03-16
$2.30M
derived: sum of 2 quarters · filed 2016-03-16
$3.34M
10-Q · filed 2016-03-16
$4.33M
derived: sum of 4 quarters · filed 2016-03-16
2014-10-31$1.20M
10-Q · filed 2015-12-15
$2.25M
10-Q · filed 2015-12-15
$3.23M
derived: sum of 3 quarters · filed 2015-12-15
$4.05M
derived: sum of 4 quarters · filed 2015-12-15
2014-07-31$1.03M
10-Q · filed 2015-09-11
$2.03M
derived: sum of 2 quarters · filed 2015-09-11
$2.85M
derived: sum of 3 quarters · filed 2015-09-11
$3.55M
derived: sum of 4 quarters · filed 2015-09-11
2014-04-30$995.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-29
$1.82M
derived: sum of 2 quarters · filed 2015-07-29
$2.51M
derived: sum of 3 quarters · filed 2015-07-29
$3.15M
10-K · filed 2015-07-29
2014-01-31$821.00K
10-Q · filed 2015-03-17
$1.52M
derived: sum of 2 quarters · filed 2015-03-17
$2.16M
10-Q · filed 2015-03-17
$2.78M
derived: sum of 4 quarters · filed 2015-03-17
2013-10-31$698.00K
10-Q · filed 2014-12-15
$1.34M
10-Q · filed 2014-12-15
$1.96M
derived: sum of 3 quarters · filed 2014-12-15
$2.62M
derived: sum of 4 quarters · filed 2014-12-15
2013-07-31$642.00K
10-Q · filed 2014-09-12
$1.26M
derived: sum of 2 quarters · filed 2014-09-12
$1.92M
derived: sum of 3 quarters · filed 2014-09-12
$2.60M
derived: sum of 4 quarters · filed 2014-09-12
2013-04-30$618.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-07-28
$1.28M
derived: sum of 2 quarters · filed 2014-07-28
$1.96M
derived: sum of 3 quarters · filed 2014-07-28
$2.67M
10-K · filed 2014-07-28
2013-01-31$658.00K
10-Q · filed 2014-03-14
$1.34M
derived: sum of 2 quarters · filed 2014-03-14
$2.05M
10-Q · filed 2014-03-14
$3.09M
derived: sum of 4 quarters · filed 2014-03-14
2012-10-31$680.00K
10-Q · filed 2013-12-13
$1.39M
10-Q · filed 2013-12-13
$2.43M
derived: sum of 3 quarters · filed 2013-12-13
$3.06M
derived: sum of 4 quarters · filed 2013-12-13
2012-07-31$709.00K
10-Q · filed 2013-09-13
$1.75M
derived: sum of 2 quarters · filed 2013-09-13
$2.38M
derived: sum of 3 quarters · filed 2013-09-13
$3.03M
derived: sum of 4 quarters · filed 2013-09-13
2012-04-30$1.04M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-26
$1.67M
derived: sum of 2 quarters · filed 2013-07-26
$2.32M
derived: sum of 3 quarters · filed 2013-07-26
$2.93M
10-K · filed 2013-07-26
2012-01-31$623.00K
10-Q · filed 2013-03-13
$1.27M
derived: sum of 2 quarters · filed 2013-03-13
$1.89M
10-Q · filed 2013-03-13
$2.69M
derived: sum of 4 quarters · filed 2013-03-13
2011-10-31$651.00K
10-Q · filed 2012-12-13
$1.26M
10-Q · filed 2012-12-13
$2.07M
derived: sum of 3 quarters · filed 2012-12-13
$2.31M
derived: sum of 4 quarters · filed 2012-12-13
2011-07-31$688.00K
10-Q · filed 2012-09-12
$1.42M
derived: sum of 2 quarters · filed 2012-09-12
$1.66M
derived: sum of 3 quarters · filed 2012-09-12
$1.74M
derived: sum of 4 quarters · filed 2012-09-12
2011-04-30$729.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-07-18
$968.00K
derived: sum of 2 quarters · filed 2012-07-18
$1.05M
derived: sum of 3 quarters · filed 2012-07-18
$1.08M
10-K · filed 2012-07-18
2011-01-31$239.00K
10-Q · filed 2012-03-14
$319.00K
derived: sum of 2 quarters · filed 2012-03-14
$356.00K
10-Q · filed 2012-03-14
2010-10-31$80.00K
10-Q · filed 2011-12-14
$116.00K
10-Q · filed 2011-12-14
2010-07-31$134.00K
10-Q · filed 2011-09-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
BioStem Technologies, Inc. (BSEM)United States$0.069B
Kalaris Therapeutics, Inc. (KLRS)United States$0.073B-2.19
Eloxx Pharmaceuticals, Inc. (ELOX)United States$0.065B
MiNK Therapeutics, Inc. (INKT)United States$0.063B-5.37
Vaxart, Inc. (VXRT)United States$0.080B3.84
EXOZYMES INC. (EXOZ)United States$0.058B
BioAtla, Inc. (BCAB)United States$0.058B-0.21
ImageneBio, Inc. (IMA)United States$0.056B-1.31
Inmune Bio, Inc. (INMB)United States$0.056B-2.48
Atara Biotherapeutics, Inc. (ATRA)United States$0.086B-6.48